Drug Profile
Research programme: antibacterials - Lupin
Alternative Names: Antibacterials research programme - Lupin; LL-3522; LL-4858Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Lupin
- Class Pyrroles
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in India
- 12 Nov 2004 Data presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2004) have been added to the Bacterial infections antimicrobial activity and pharmacodynamics sections ,
- 02 Sep 2004 Preclinical trials in Bacterial infections in India (unspecified route)